{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:55:02Z","timestamp":1759366502242,"version":"build-2065373602"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.revmed.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T04:04:33Z","timestamp":1623989073000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Les maladies \u00e0 prions ou enc\u00e9phalopathies spongiformes transmissibles"],"prefix":"10.1016","volume":"43","author":[{"given":"J.-P.","family":"Brandel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2021.05.002_bib0510","first-page":"1552","article-title":"La maladie dite tremblante du mouton est-elle inoculable\u00a0?","volume":"203","author":"Cuill\u00e9","year":"1936","journal-title":"C R Acad Sci"},{"key":"10.1016\/j.revmed.2021.05.002_bib0515","first-page":"78","article-title":"La tremblante du mouton est bien inoculable","volume":"206","author":"Cuill\u00e9","year":"1938","journal-title":"C R Acad Sci Paris"},{"key":"10.1016\/j.revmed.2021.05.002_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02866081","article-title":"Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems","volume":"57","author":"Creutzfeldt","year":"1920","journal-title":"Z Neurol U Psychiatr"},{"key":"10.1016\/j.revmed.2021.05.002_bib0525","first-page":"132","article-title":"Uber eine eigenartige Erkrankung des Zentral-nervensystems mit bemerkenswertem anatomischem Befunde (spastische pseudosklerotische Encephalomyelopathie mit disseminierten Degenerationsherden)","volume":"70","author":"Jakob","year":"1921","journal-title":"Dtsch Z Nervenheilk"},{"key":"10.1016\/j.revmed.2021.05.002_bib0530","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(59)92081-1","article-title":"Scrapie and kuru","volume":"2","author":"Hadlow","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0535","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/209794a0","article-title":"Experimental transmission of a kuru-like syndrome in chimpanzees","volume":"209","author":"Gajdusek","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2021.05.002_bib0540","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.161.3839.388","article-title":"Creutzfeldt-Jakob disease (subacute spongiform encephalopathy): transmission to the chimpanzee","volume":"161","author":"Gibbs","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0545","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0140-6736(91)92583-N","article-title":"Creutzfeldt-Jakob disease in children treated with growth hormone","volume":"337","author":"Billette de Villemeur","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0550","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0555","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(61)92008-6","article-title":"Encephalopathy in mice produced by inoculation with scrapie brain material","volume":"1","author":"Chandler","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0560","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0565","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0022-2836(02)00856-2","article-title":"Amyloidogenic unfolding intermediates differentiate sheep prion protein variants","volume":"322","author":"Rezaei","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0570","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/382180a0","article-title":"NMR structure of the mouse prion protein domain PrP (121-231)","volume":"282","author":"Riek","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2021.05.002_bib0575","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.97.1.145","article-title":"NMR solution structure of the human prion protein","volume":"97","author":"Zahn","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.revmed.2021.05.002_bib0580","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-5793(96)01104-0","article-title":"Metal-dependent alpha-helix formation promoted by the glycine-rich octapeptide region of prion protein","volume":"396","author":"Miura","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.revmed.2021.05.002_bib0585","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1126\/science.289.5486.1925","article-title":"Signal transduction through prion protein","volume":"289","author":"Mouillet-Richard","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0590","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1093\/emboj\/20.21.5863","article-title":"The 37-kDa\/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein","volume":"20","author":"Gauczynski","year":"2001","journal-title":"Embo J"},{"key":"10.1016\/j.revmed.2021.05.002_bib0595","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/370295a0","article-title":"Prion protein is necessary for normal synaptic function","volume":"370","author":"Collinge","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2021.05.002_bib0600","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.4049\/jimmunol.176.12.7254","article-title":"Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells","volume":"176","author":"Ballerini","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0605","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","article-title":"Mice devoid of PrP are resistant to scrapie","volume":"73","author":"B\u00fceler","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2021.05.002_bib0610","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0615","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.6815801","article-title":"Identification of a protein that purifies with the scrapie prion","volume":"218","author":"Bolton","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0620","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0092-8674(85)90076-5","article-title":"Identification of prion amyloid filaments in scrapie-infected brain","volume":"41","author":"DeArmond","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2021.05.002_bib0625","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/j.1460-2075.1986.tb04539.x","article-title":"The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein","volume":"5","author":"Hope","year":"1986","journal-title":"EMBO J"},{"key":"10.1016\/j.revmed.2021.05.002_bib0630","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1359-0278(96)00007-7","article-title":"Scrapie prions: a three-dimensional model of an infectious fragment","volume":"1","author":"Huang","year":"1996","journal-title":"Fold Des"},{"key":"10.1016\/j.revmed.2021.05.002_bib0635","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","article-title":"In vitro generation of infectious scrapie prions","volume":"121","author":"Castilla","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2021.05.002_bib0640","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1073\/pnas.0605608103","article-title":"Cell-free formation of misfolded prion protein with authentic prion infectivity","volume":"103","author":"Weber","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2021.05.002_bib0645","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1073\/pnas.0702662104","article-title":"Formation of native prions from minimal components in vitro","volume":"104","author":"Deleault","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2021.05.002_bib0650","doi-asserted-by":"crossref","first-page":"14083","DOI":"10.1074\/jbc.C110.113464","article-title":"Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors","volume":"285","author":"Kim","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2021.05.002_bib0655","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.1100195","article-title":"Synthetic mammalian prions","volume":"305","author":"Legname","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0660","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1073\/pnas.0409079102","article-title":"Strain-specified characteristics of mouse synthetic prions","volume":"102","author":"Legname","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2021.05.002_bib0665","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.12688\/f1000research.12681.1","article-title":"Creutzfeldt-Jakob disease: recent developments","volume":"6","author":"Mackenzie","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.revmed.2021.05.002_bib0670","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.46.5.1287","article-title":"Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies","volume":"46","author":"Wientjens","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0675","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(97)09468-3","article-title":"Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD)","volume":"351","author":"van Duijn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0680","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(98)08138-0","article-title":"Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study","volume":"353","author":"Collins","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0685","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.59.4.543","article-title":"Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls","volume":"59","author":"Ward","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0690","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/01.WNL.0000145844.53251.BC","article-title":"A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering","volume":"63","author":"Linsell","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0695","first-page":"25","article-title":"Electrophysiological approach of transmissible encephalopathies or prion diseases","volume":"43","author":"Court","year":"1995","journal-title":"Pathol Biol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0700","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archneur.1996.00550020074017","article-title":"Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease","volume":"53","author":"Steinhoff","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0705","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease","volume":"129","author":"Collins","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2021.05.002_bib0710","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/archneur.57.12.1751","article-title":"Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease","volume":"57","author":"Schroter","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0715","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/01.WNL.0000134555.59460.5D","article-title":"abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease","volume":"63","author":"Shiga","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0720","first-page":"1459","article-title":"Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences","volume":"27","author":"Kallenberg","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0725","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.58.1.148-a","article-title":"Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar","volume":"58","author":"Haik","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0730","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000017095","article-title":"14-3-3\u00a0protein, neuron-specific enolase, and S-100\u00a0protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"10","author":"Beaudry","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.revmed.2021.05.002_bib0735","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3\u00a0brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies","volume":"335","author":"Hsich","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2021.05.002_bib0740","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(01)01619-6","article-title":"Determination of 14-3-3\u00a0protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay","volume":"301","author":"Peoc\u2019h","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.revmed.2021.05.002_bib0745","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","article-title":"The role of cerebrospinal fluid 14-3-3\u00a0and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review","volume":"81","author":"Chohan","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2021.05.002_bib0750","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2021.05.002_bib0755","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0760","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","article-title":"Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt\u2013Jakob disease","volume":"53","author":"Cramm","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0765","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3988\/jcn.2016.12.1.101","article-title":"Real-Time quaking-induced conversion analysis for the diagnosis of sporadic Creutzfeldt\u2013Jakob disease in Korea","volume":"12","author":"Park","year":"2016","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.378","article-title":"Extended and direct evaluation of RT-QuIC assays for Creutzfeldt\u2013Jakob disease diagnosis","volume":"4","author":"Groveman","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0775","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1212\/WNL.44.12.2347","article-title":"Molecular genetics of prion diseases in France","volume":"44","author":"Laplanche","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0780","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300\u00a0subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0785","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2807\/1560-7917.ES.2017.22.41.16-00715","article-title":"Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3\u00a0protein, France, 1992\u00a0to 2009","volume":"22","author":"Peckeu","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.revmed.2021.05.002_bib0790","first-page":"633","article-title":"Genetic epidemiology of Creutzfeldt-Jakob disease in Europe","volume":"157","author":"Group","year":"2001","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0795","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(03)00323-5","article-title":"Familial and sporadic fatal insomnia","volume":"2","author":"Montagna","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0800","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/hmg\/4.6.1109","article-title":"Two novel insertions in the prion protein gene in patients with late-onset dementia","volume":"4","author":"Laplanche","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0805","first-page":"152","article-title":"Gerstmann-Straussler-Scheinker syndrome","volume":"154","author":"Tranchant","year":"1998","journal-title":"Rev Neurol"},{"issue":"Pt10","key":"10.1016\/j.revmed.2021.05.002_bib0810","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/brain\/122.10.1823","article-title":"Inherited prion disease with an alanine to valine mutation at codon\u00a0117\u00a0in the prion protein gene","volume":"122","author":"Mallucci","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2021.05.002_bib0815","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0820","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1093\/hmg\/dds377","article-title":"Substitutions at residue\u00a0211\u00a0in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders","volume":"21","author":"Peoc\u2019h","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0825","first-page":"131","article-title":"Diseases transmissible by non-conventional agents: nosology and diagnosis","volume":"154","author":"Hauw","year":"1998","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0830","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1750-3639.1998.tb00172.x","article-title":"Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon\u00a0129\u00a0of the prion protein gene","volume":"8","author":"Montagna","year":"1998","journal-title":"Brain Pathol"},{"issue":"Suppl.1","key":"10.1016\/j.revmed.2021.05.002_bib0835","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2869.1999.00005.x","article-title":"Fatal familial insomnia: clinical features and molecular genetics","volume":"8","author":"Cortelli","year":"1999","journal-title":"J Sleep Res"},{"key":"10.1016\/j.revmed.2021.05.002_bib0840","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1098\/rstb.2008.0068","article-title":"A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea","volume":"363","author":"Collinge","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.revmed.2021.05.002_bib0845","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM197403212901220","article-title":"Possible person-to-person transmission of Creutzfeldt-Jakob disease","volume":"290","author":"Duffy","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2021.05.002_bib0850","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.wnl.0000231528.65069.3f","article-title":"Iatrogenic Creutzfeldt-Jakob disease: the waning of an era","volume":"67","author":"Brown","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0855","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic Creutzfeldt-Jakob disease, final assessment","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.revmed.2021.05.002_bib0860","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(03)13867-6","article-title":"Distribution of codon 129\u00a0genotype in human growth hormone-treated CJD patients in France and the UK","volume":"362","author":"Brandel","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0865","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cid\/ciz692","article-title":"Factors Influencing the Incubation of an Infectious Form of CJD","volume":"70","author":"Peckeu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2021.05.002_bib0870","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","article-title":"Iatrogenic Creutzfeldt-Jakob disease at the millennium","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0875","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.47.3.690","article-title":"Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France","volume":"47","author":"Billette de Villemeur","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0880","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1531-8249(20010201)49:2<257::AID-ANA48>3.0.CO;2-X","article-title":"14-3-3\u00a0protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients","volume":"49","author":"Brandel","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0885","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3201\/eid1308.070178","article-title":"Source of variant Creutzfeldt-Jakob disease outside United Kingdom","volume":"13","author":"Sanchez-Juan","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.revmed.2021.05.002_bib0890","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1066838","article-title":"Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom","volume":"294","author":"Valleron","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0895","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1126\/science.1064748","article-title":"Predictability of the UK variant Creutzfeldt-Jakob disease epidemic","volume":"294","author":"d\u2019Aignaux","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0900","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ije\/dyg248","article-title":"Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940\u00a0to 1969\u00a0and post-1969\u00a0birth cohorts","volume":"32","author":"Cooper","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0905","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ije\/dyh374","article-title":"Risk of variant Creutzfeldt-Jakob disease in France","volume":"34","author":"Chadeau-Hyam","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0910","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0915","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0920","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.revmed.2021.05.002_bib0925","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(00)02140-1","article-title":"The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease","volume":"355","author":"Zeidler","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.05.002_bib0930","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.70.6.744","article-title":"Use of 14-3-3\u00a0and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease","volume":"70","author":"Green","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2021.05.002_bib0935","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJMc1610003","article-title":"Joiner S.\u00a0vCJD in a patient with heterozygosity at PRNP codon 129","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2021.05.002_bib0940","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1257","article-title":"Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease","volume":"8","author":"Bougard","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.revmed.2021.05.002_bib0945","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3201\/eid2407.172105","article-title":"Diagnosis of methionine\/valine variant Creutzfeldt-Jakob disease by protein misfolding cyclic amplification","volume":"24","author":"Bougard","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.revmed.2021.05.002_bib0950","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.21583","article-title":"Variant Creutzfeldt-Jakob disease in France and the United Kingdom: evidence for the same agent strain","volume":"65","author":"Brandel","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0955","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3201\/eid1810.120792","article-title":"Constant transmission properties of variant Creutzfeldt-Jakob disease in 5\u00a0countries","volume":"18","author":"Diack","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.revmed.2021.05.002_bib0960","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1212\/01.WNL.0000148596.15681.4D","article-title":"Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects","volume":"63","author":"Haik","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0965","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","article-title":"Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study","volume":"62","author":"Otto","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0970","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1474-4422(09)70049-3","article-title":"Safety and efficacy of quinacrine in human prion disease (PRION-1\u00a0study): a patient-preference trial","volume":"8","author":"Collinge","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0975","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.0b013e3182a9f3b4","article-title":"Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease","volume":"81","author":"Geschwind","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.05.002_bib0980","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/jnnp-2013-305590","article-title":"Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate","volume":"85","author":"Newman","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2021.05.002_bib0985","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.276.5315.1119","article-title":"Effectiveness of anthracycline against experimental prion disease in Syrian hamsters","volume":"276","author":"Tagliavini","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.05.002_bib0990","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0995","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2021.05.002_bib1000","doi-asserted-by":"crossref","first-page":"e1888","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2021.05.002_bib1005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Haik","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2021.05.002_bib0505","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/jit623","article-title":"Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific","volume":"209","author":"Hannaoui","year":"2014","journal-title":"J Infect Dis"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321004513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321004513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:44:37Z","timestamp":1759337077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866321004513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0248866321004513"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2021.05.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les maladies \u00e0 prions ou enc\u00e9phalopathies spongiformes transmissibles","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}